Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-08 · accession 0001209191-22-045179 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-10 | 2022-08-08+ | IRWD | Rickard Jason | SVP, COO | S - Sale+OE | $11.68 | -47.5K | 379.0K | -11% | -$554.4K |
| D | 2022-08-10 | 2022-08-09 | IRWD | Rickard Jason | SVP, COO | M - OptEx | $11.65 | +18.0K | 394.8K | +5% | +$210.2K |
| D | 2022-08-10 | 2022-08-09 | IRWD | Rickard Jason | SVP, COO | M - OptEx | $0.00 | -18.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-08-08 | S | D | 2,236 | $11.56 | 376,730 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-08-09 | S | D | 18,041 | $11.75 | 376,730 | D | — | — | (F3) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.74 to $11.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Class A Common Stock | 2022-08-09 | M | A | 18,041 | $11.65 | 394,771 | D | — | — | |
| 4 | Common | Class A Common Stock | 2022-08-08 | S | D | 27,200 | $11.64 | 378,966 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.63 to $11.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. (F2) The reporting person acquired 2,092 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2022. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2022-08-09 | M | D | 18,041 | $0.00 | 0 | D | $11.65 · — to 2023-02-01 | 18,041 Class A Common Stock | (F4) This option, granted as an annual performance award, is presently exercisable in full. |